Coenzyme Q10inhibits mitochondrial complex‐1 down‐regulation and nuclear factor‐kappa B activation

Authors:

Abstract
We have used control‐homozygous weaver mutant, and ‐heterozygous weaver mutant mice in order to explore the basic molecular mechanism of neurodegeneration and the neuroprotective potential of coenzyme Q10. Homozygous weaver mutant mice exhibited progressive neurodegeneration in the hippocampus, striatum, and cerebellum, and a reduction in the striatal levels of dopamine and coenzyme Qs (Q9and Q10) without any significant changes in norepinephrine and serotonin. Mitochondrial complex‐1 was down regulated; whereas nuclear factor‐kappa B was up regulated in homozygous weaver mutant mice. Rotenone inhibited complex‐1, enhanced nuclear factor‐kappa B, and caused apoptosis in human dopaminergic (SK‐N‐SH) neurons; whereas nuclear factor‐kappa B antibody suppressed rotenone‐induced apoptosis, suggesting that enhancing coenzyme Q10synthesis and suppressing the induction of NF‐kappa B, may provide neuroprotection.

This publication has 15 references indexed in Scilit: